Researchers in South Korea have proposed a novel cancer immunotherapy approach that could complement existing CAR-T (Chimeric Antigen Receptor T-cell) treatments.
Novel cancer immunotherapy approach could complement existing CAR-T treatments
- Post author:admin
- Post published:April 24, 2025
- Post category:uncategorized